Apollon Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Buy |
96,041
+3,301
| +4% | +$386K | 0.15% | 133 |
|
|
2026
Q1 | $11.2M | Buy |
92,740
+2,665
| +3% | +$308K | 0.18% | 116 |
|
|
2025
Q4 | $9.48M | Buy |
90,075
+791
| +0.9% | +$74.3K | 0.16% | 120 |
|
|
2025
Q3 | $7.49M | Sell |
89,284
-1,203
| -1% | -$99.1K | 0.13% | 146 |
|
|
2025
Q2 | $7.16M | Sell |
90,487
-2,160
| -2% | -$172K | 0.14% | 138 |
|
|
2025
Q1 | $8.32M | Sell |
92,647
-5,068
| -5% | -$473K | 0.18% | 112 |
|
|
2024
Q4 | $9.72M | Sell |
97,715
-1,574
| -2% | -$162K | 0.22% | 83 |
|
|
2024
Q3 | $11.3M | Sell |
99,289
-5,538
| -5% | -$658K | 0.32% | 62 |
|
|
2024
Q2 | $13M | Buy |
104,827
+3,625
| +4% | +$467K | 0.4% | 49 |
|
|
2024
Q1 | $13.4M | Buy |
101,202
+2,787
| +3% | +$344K | 0.42% | 48 |
|
|
2023
Q4 | $10.7M | Buy |
98,415
+22,991
| +30% | +$2.39M | 0.37% | 52 |
|
|
2023
Q3 | $7.76M | Buy |
75,424
+437
| +0.6% | +$47.1K | 0.39% | 54 |
|
|
2023
Q2 | $8.65M | Buy |
74,987
+252
| +0.3% | +$28.6K | 0.42% | 46 |
|
|
2023
Q1 | $7.95M | Buy |
74,735
+3,041
| +4% | +$328K | 0.49% | 37 |
|
|
2022
Q4 | $7.95M | Buy |
71,694
+9,195
| +15% | +$940K | 0.56% | 27 |
|
|
2022
Q3 | $5.38M | Buy |
62,499
+2,585
| +4% | +$231K | 0.44% | 42 |
|
|
2022
Q2 | $5.46M | Buy |
59,914
+595
| +1% | +$52.7K | 0.45% | 38 |
|
|
2022
Q1 | $4.87M | Sell |
59,319
-1,530
| -3% | -$121K | 0.35% | 58 |
|
|
2021
Q4 | $4.66M | Buy |
60,849
+21,613
| +55% | +$1.72M | 0.35% | 59 |
|
|
2021
Q3 | $2.95M | Buy |
39,236
+20,738
| +112% | +$1.58M | 0.4% | 46 |
|
|
2021
Q2 | $1.44M | Sell |
18,498
-1,824
| -9% | -$136K | 0.26% | 76 |
|
|
2021
Q1 | $1.5M | Buy |
20,322
+14,839
| +271% | +$1.09M | 0.29% | 69 |
|
|
2020
Q4 | $428K | Sell |
5,483
-5,110
| -48% | -$391K | 0.12% | 132 |
|
|
2020
Q3 | $838K | Buy |
10,593
+3,025
| +40% | +$237K | 0.38% | 66 |
|
|
2020
Q2 | $558K | Buy |
7,568
+3,237
| +75% | +$244K | 0.31% | 51 |
|
|
2020
Q1 | $318K | Sell |
4,331
-157
| -3% | -$12.3K | 0.33% | 43 |
|
|
2019
Q4 | $383K | Sell |
4,488
-70
| -2% | -$5.75K | 0.34% | 42 |
|
|
2019
Q3 | $366K | Sell |
4,558
-378
| -8% | -$30.3K | 0.38% | 41 |
|
|
2019
Q2 | $395K | Buy |
4,936
+80
| +2% | +$6.13K | 0.45% | 33 |
|
|
2019
Q1 | $385K | Sell |
4,856
-84
| -2% | -$6.28K | 0.51% | 34 |
|
|
2018
Q4 | $351K | Buy |
+4,940
| New | +$349K | 0.32% | 34 |
|
Other funds holding MRK
Apollon Wealth Management's MRK Position: Q2 2026 in Review
Apollon Wealth Management increased its Merck (MRK) stake by 3.6% in Q2 2026, buying an estimated $386K and bringing the position to 96,041 shares worth $12.3M. The position accounts for 0.15% of the portfolio, ranked #133.
Apollon Wealth Management first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $13.4M in Q1 2024. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Apollon Wealth Management held 96,041 shares of Merck worth $12.3M as of Q2 2026.
- Apollon Wealth Management bought 3,301 Merck shares in Q2 2026, an estimated $386K.
- Merck made up 0.15% of Apollon Wealth Management's portfolio in Q2 2026, its #133 holding.
- Apollon Wealth Management first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Apollon Wealth Management's Merck position peaked at $13.4M in Q1 2024.
- 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.